Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-31

Clinical Trial Update: Cell Repair in Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of cell repair therapy for heart failure and ischemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Heart Failure, Ischemia | Phase 1, Phase 2 | Status: WITHDRAWN